Genetic Testing in Egyptian Patients with Inborn Errors of Immunity: a Single-Center Experience

J Clin Immunol. 2022 Jul;42(5):1051-1070. doi: 10.1007/s10875-022-01272-y. Epub 2022 Apr 28.

Abstract

Background: Inborn errors of immunity (IEI) are a group of heterogeneous disorders with geographic and ethnic diversities. Although IEI are common in Egypt, genetic diagnosis is limited due to financial restrictions. This study aims to characterize the genetic spectrum of IEI patients in Egypt and highlights the adaptation of the molecular diagnostic methods to a resource-limited setting.

Methods: Genetic material from 504 patients was studied, and proper diagnosis was achieved in 282 patients from 246 families. Mutational analysis was done by Sanger sequencing, next-generation sequencing (NGS) targeting customized genes panels, and whole-exome sequencing (WES) according to the patients' phenotypes and availability of genetic testing.

Results: A total of 194 variants involving 72 different genes were detected with RAG1/2 genes being the most encountered followed by DOCK8, CYBA, LRBA, NCF1, and JAK3. Autosomal recessive (AR) inheritance was detected in 233/282 patients (82.6%), X-linked (XL) recessive inheritance in 32/282 patients (11.3%), and autosomal dominant (AD) inheritance in 18/282 patients (6.4%), reflecting the impact of consanguineous marriages on the prevalence of different modes of inheritance and the distribution of the various IEI disorders.

Conclusion: The study showed that a combination of Sanger sequencing in selected patients associated with targeted NGS or WES in other patients is an effective diagnostic strategy for IEI diagnosis in countries with limited diagnostic resources. Molecular testing can be used to validate other nonexpensive laboratory techniques that help to reach definitive diagnosis and help in genetic counseling and taking proper therapeutic decisions including stem cell transplantation or gene therapy.

Keywords: Human inborn errors of immunity; genetic diagnosis; networking; personalized treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Consanguinity
  • Egypt / epidemiology
  • Genetic Diseases, Inborn
  • Genetic Testing* / methods
  • Guanine Nucleotide Exchange Factors
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Immune System Diseases* / diagnosis
  • Immune System Diseases* / genetics
  • Phenotype

Substances

  • Adaptor Proteins, Signal Transducing
  • DOCK8 protein, human
  • Guanine Nucleotide Exchange Factors
  • LRBA protein, human